IPA Stock Price | Immunoprecise Antibodies Ltd P/E, Revenue, EPS, & Forecasts

Immunoprecise Antibodies Ltd • IPA

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

About Immunoprecise Antibodies Ltd

Ticker

IPA

Trading on

NASDAQ

ISIN

CA45257F2008

Industry

Biotechnology

Sector

Healthcare

CEO

Dr. Jennifer Lynne Bath Ph.D.

Headquarters

Industrious 823 Congress Ave, Austin, TX, United States, 78701

Employees

Website

ipatherapeutics.com

ImmunoPrecise Antibodies Ltd. operates as an AI-driven biotherapeutic research, technology, and scientifically robust life science company. It discovers and develops customized and novel antibodies by generating proprietary and patented processes, procedures, and innovative approaches to antibody discovery, development, and production. The company was incorporated in 1983 and is headquartered in Austin, Texas.

Metrics

BasicAdvanced

Market cap

$95.5M

P/E ratio

EPS

-$0.66

Dividend Yield

0.00%

Beta

0.55

Forward P/E ratio

EBIDTA

$-9.3M

Ex dividend date

Price & volume

Market cap

$95.5M

Average daily volume

90-day return

30-day return

7-day return

Dividends

Dividend per share

$0.00

Dividend yield

0.00%

Forward dividend per share

$0.00

Forward dividend yield

0.00%

Payout ratio

0.00%

Valuation

P/E ratio

Forward P/E

PEG ratio

Trailing P/E

Price to sales

3.9

Price to book

5.61

Earnings

EPS

-$0.66

EPS estimate (current quarter)

$0.00

EPS estimate (next quarter)

$0.00

EBITDA

$-9.3M

Revenues (TTM)

$24.5M

Revenues per share (TTM)

$0.73

Technicals

Beta

0.55

52-week High

$3.25

52-week Low

$0.27

50-day moving average

$1.90

200-day moving average

$0.83

Short ratio

0.31

Short %

0.95%

Management effectiveness

ROE (TTM)

-101.96%

ROA (TTM)

-14.81%

Profit margin

-123.30%

Gross profit margin

$13.5M

Operating margin

-21.11%

Growth

Quarterly earnings growth (YoY)

0.00%

Quarterly revenue growth (YoY)

8.10%

Share stats

Outstanding Shares

46.2M

Float

41.9M

Insiders %

9.07%

Institutions %

8.67%

Analyst Insights & forecasts

100% Buy

0% Hold

0% Sell

Based on information from 2 analysts.

Average price target

$4.00

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

-$0.11

-$0.08

-37.50%

Q3 • 24Missed

-$0.06

-$0.07

9.00%

Q4 • 24Beat

-$0.46

-$0.06

-724.82%

Q1 • 25Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$6.2M

$-21.5M

-349.88%

Q1 • 25

$7M

$-2.2M

-30.96%

Q2 • 25

13.49%

-89.96%

-91.15%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$45.5M

$20.4M

44.82%

Q1 • 25

$44.4M

$20.8M

46.84%

Q2 • 25

-2.40%

1.98%

4.49%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$-1.2M

$-0.1M

$10.5M

$-1.3M

Q1 • 25

$-1.1M

$-0.4M

$-1.5M

Q2 • 25

-5.24%

220.54%

-103.96%

13.99%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Immunoprecise Antibodies Ltd share?

Immunoprecise Antibodies Ltd shares are currently traded for undefined per share.

How many shares does Immunoprecise Antibodies Ltd have?

Immunoprecise Antibodies Ltd currently has 46.2M shares.

Does Immunoprecise Antibodies Ltd pay dividends?

No, Immunoprecise Antibodies Ltd doesn't pay dividends.

What is Immunoprecise Antibodies Ltd 52 week high?

Immunoprecise Antibodies Ltd 52 week high is $3.25.

What is Immunoprecise Antibodies Ltd 52 week low?

Immunoprecise Antibodies Ltd 52 week low is $0.27.

What is the 200-day moving average of Immunoprecise Antibodies Ltd?

Immunoprecise Antibodies Ltd 200-day moving average is $0.83.

Who is Immunoprecise Antibodies Ltd CEO?

The CEO of Immunoprecise Antibodies Ltd is Dr. Jennifer Lynne Bath Ph.D..

How many employees Immunoprecise Antibodies Ltd has?

Immunoprecise Antibodies Ltd has 81 employees.

What is the market cap of Immunoprecise Antibodies Ltd?

The market cap of Immunoprecise Antibodies Ltd is $95.5M.

What is the P/E of Immunoprecise Antibodies Ltd?

The current P/E of Immunoprecise Antibodies Ltd is null.

What is the EPS of Immunoprecise Antibodies Ltd?

The EPS of Immunoprecise Antibodies Ltd is -$0.66.

What is the PEG Ratio of Immunoprecise Antibodies Ltd?

The PEG Ratio of Immunoprecise Antibodies Ltd is null.

What do analysts say about Immunoprecise Antibodies Ltd?

According to the analysts Immunoprecise Antibodies Ltd is considered a buy.